Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Wednesday 15 August, 2007

Lipoxen PLC

Holding(s) in Company

Lipoxen PLC
15 August 2007

                          Lipoxen PLC (the 'Company')



                              Holdings in Company



The Company announces that it was informed on 28 July 2007 that  FDS Pharma
disposed of a total of 4,355,030 ordinary shares of the Company in three
separate transactions that took place in May and June 2007. As a result of these
transactions, FDS Pharma's total shareholding now amounts to 41,494,934 ordinary
shares of the Company which represents 34.70% of the Company's current issued
and outstanding ordinary shares and voting rights.



15 August 2007



Enquiries:



Lipoxen PLC

M. Scott Maguire, CEO                                       +44 (0)20 7691 3583



Grant Thornton Corporate Finance

Philip J Secrett                                            +44 (0)20 7383 5100






                      This information is provided by RNS
            The company news service from the London Stock Exchange